A& Tax Managing Director Dan Peters was recently featured in Bloomberg Tax's article, 'Trump Pharma Pricing Order Piles on Transfer Pricing'. This article outlines President Donald Trump's executive order related to lowering US medicine prices and explores its implications for transfer pricing and existing tariff policies.
"It’s the latest in a series of things causing pharmaceutical companies to reconsider all aspects of their international tax planning and their transfer pricing, and even further, how they organize their supply chain.”
Mr. Peters provides his perspective on the order, commenting on its anticipated effects on pharmaceutical company's international tax planning and supply chain organization.
Read The Full Article
A&M Tax Policy Insights – February 2026
March 26, 2026
A&M Tax Policy Insights covers Pillar One fallout, DST trends, UN talks, and key global tax updates, tariffs, and treaties impacting cross‑border operations.
IRS Creates Limited Opportunity to Revisit “Irrevocable” §163(j) Elections
March 25, 2026
Revenue Procedure 2026-17 creates a limited window to revoke certain “irrevocable” §163(j) elections, including the RPTOB and CFC group elections, in light of OBBBA-driven changes.
India Tax Alert | The Corporate Laws (Amendment) Bill, 2026
March 25, 2026
The Bill represents a significant shift toward streamlining corporate restructuring and reducing the regulatory friction for M&A transactions. Here is a summary of the key provisions from an M&A and restructuring perspective.
New Tax Treaty Between Spain and the Netherlands: Signing Approved by the Spanish Council of Ministers and the Expected Impact on Spanish Real Estate Investments
March 24, 2026
On March 10, 2026, the Spanish Council of Ministers approved the signing of a new double tax treaty between Spain and the Netherlands, formally replacing the current agreement signed in 1971, one of the oldest treaties in Spain’s tax treaty network.
